In line with this hypothesis [111], investigations in animal models found no tumor-aggravating effect of intra-cardially administered allogeneic MSCs on precancerous lesions [113] or when using MSCs as a delivery vehicle for IFN-γ in an NB mouse model [59]. Here, IFNG is linked to neoplasm.